haematology
Blood cancers

WEHI apoptosis research may help overcome venetoclax resistance


Victorian researchers have characterised a protein, VDAC2, as a key component of the apoptosis process and resistance to anti-cancer agents such as venetoclax. Walter and Eliza Hall Institute scientists have identified VDAC2 (voltage-dependent anion channel 2) as important for the function of the protein BAX to drive apoptotic cell death. BAX is one of two ...

Already a member?

Enter your email to keep reading.


OR